Ftag of the Week – F605 Right to be Free from Chemical Restraints (Pt. 4)

F605 Part 4 continues the discussion on gradual dose reductions (GDRs) by reviewing when a GDR may be considered clinically contraindicated and what CMS expects facilities to document in these situations. This post outlines the regulatory requirements for demonstrating why a GDR cannot be safely attempted, the type of monitoring and clinical justification surveyors look for, and the documentation needed to support ongoing psychotropic medication use. Actual deficiency examples highlight how inadequate assessment, monitoring, or justification can lead to citations under F605.